Dr. Rehan A. Kahloon, MD

Dr. Kahloon practices at Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health.

Dr. Kahloon's NPI, 1497015150, was assigned on May 29, 2012. Dr. Kahloon holds Tennessee license 59338.

Dr. Kahloon's primary practice is Erlanger Baroness Hospital, at 975 E 3rd St, Chattanooga, TN 37403 in Hamilton County. The practice phone is (423) 778-7000.

Dr. Kahloon's primary practice is Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health. Dr. Kahloon is also affiliated with Erlanger Western Carolina Hospital. The medical group on file is Erlanger. Dmand AI also links Dr. Kahloon to 2 more group practices and clinics, 1 community health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kahloon practices, 5 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kahloon's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kahloon is licensed in Tennessee.

CMS data shows 981 Medicare services from Dr. Kahloon across 13 procedure codes in 2024, for 427 Medicare patients. Medicare paid $60,948 for them.

CMS counts 427 Medicare patients who saw Dr. Kahloon in 2024. The largest group is 65 to 74, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kahloon's median patient age at 67, with 44% women.

In 2024, Dr. Kahloon wrote 2,072 Medicare Part D claims for 332 patients. 81% of them were for generic drugs. CMS names the drug for 1,988 of them, across 34 drugs with 11 or more claims each, at $384,211 in total drug cost. In 2023, CMS named 1,925 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kahloon for performance year 2024, reported through an alternative payment model (APM). Dr. Kahloon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Kahloon, published from 2012 to 2024. 2020 was the busiest year, with 4. The most frequent topics are Pulmonary Artery and Rats, Sprague-Dawley. Dr. Kahloon has published most often in Cureus. Dr. Kahloon's most frequent co-authors are Daniel Jeremy Kass, MD, Arslan A. Kahloon, MD and George Victor Moukarbel, MD.

CMS Open Payments shows 290 general payments to Dr. Kahloon from 32 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 76% of the total. Boston Scientific Corporation paid the most, $2,264.